- JP-listed companies
- FRONTEO,Inc.
- Financials
- Free cash flow
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | Free cash flow (Million JPY) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 670 | -55.32% |
| Mar 31, 2024 | 1,500 | -238.33% |
| Mar 31, 2023 | -1,084 | -146.83% |
| Mar 31, 2022 | 2,315 | +17.76% |
| Mar 31, 2021 | 1,966 | -544.04% |
| Mar 31, 2020 | -443 | -192.53% |
| Mar 31, 2019 | 479 | -62.74% |
| Mar 31, 2018 | 1,284 | -343.93% |
| Mar 31, 2017 | -526 | +821.13% |
| Mar 31, 2016 | -57 | -106.97% |
| Mar 31, 2015 | 820 |